Showing results 2 to 4 of 4
< previous
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
A Phase II study of dasatinib in patients with chemo-sensitive relapsed small cell lung cancer (SCLC): CALGB 30602 Proceeding/Conference:Journal of Thoracic Oncology | 2009 | |||
Validation of survival prognostic models for non-small-cell lung cancer in stage- and age-specific groups Proceeding/Conference:Cancer Research | 2013 | |||
Validation of the CALGB and EORTC Prognostic Models for Mesothelioma based on multiple CALGB Trials (Alliance) Proceeding/Conference:Journal of Thoracic Oncology | 2013 |